Cargando…

Flow Cytometric Analyses of the Characteristics of Tumor Cells Treated with Two Platinum Compounds: 1,1‐Cyclobutanedicarboxylato(2‐aminomethylpyrrolidine)‐platinum(II) and Cisplatin

In order to reduce the toxicities of cisplatin (DDP) and/or to improve antitumor efficacy, a large number of new platinum analogues have been synthesized. 1,1‐Cyclobutanedicarboxylato(2‐amino‐methylpyrrolidine)platinum(II) (DWA2114R) is one of them. In this study, we characterized the action mechani...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Shoichi, Mizuno, Shigetaka, Ito, Masami, Ohnuma, Takao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1992
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918718/ https://www.ncbi.nlm.nih.gov/pubmed/1483936 http://dx.doi.org/10.1111/j.1349-7006.1992.tb02750.x

Ejemplares similares

Comparison of the antitumour effects and nephrotoxicity-inducing activities of two new platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)-platinum (II) monohydrate, and its enantiomeric isomer.
por: Matsumoto, T., et al.
Publicado: (1991)

Antitumor Activity and Cellular Accumulation of a New Platinum Complex, (—)‐(R)‐2‐Aminomethylpyrrolidine(1,l‐cyclobutanedicarboxylato)platinum(II) Monohydrate, in Cisplatin‐sensitive and ‐resistant Murine P388 Leukemia Cells
por: Kamisango, Keiichi, et al.
Publicado: (1992)

Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.
por: Akamatsu, K., et al.
Publicado: (1992)

Toxicological and Tumoricidal Evaluations of a New Platinum Complex, (–)‐(R)‐2‐Aminomethy lpyrrolidine (1,1‐cyclobutanedicarboxylato) platinum (II) Monohydrate, in Rats
por: Akamatsu, Ken‐ichi, et al.
Publicado: (1991)

Sequence‐dependent Termination of Mammalian DNA Polymerase Reaction by a New Platinum Compound, (–)‐(R)‐2‐Aminomethylpyrrolidine(1,1‐cyclobutane‐dicarboxylato)‐2‐platinum(II) Monohydrate
por: Iwata, Mitsumasa, et al.
Publicado: (1991)

A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
por: Fujiwara, Y., et al.
Publicado: (1993)

Potentiation of cis‐Diammine(1, 1‐cyclobutanedicarboxylato)platinum(II) by Amphotericin B in BALB/c Nude Mice Bearing Human Ovarian Carcinoma Cells
por: Kojima, Masayoshi, et al.
Publicado: (1994)

Binding Characteristics of (–)‐(R)‐2‐Aminomethylpyrrolidine(1,1‐cyclobutanedi‐carboxylato)‐2‐platinum(II) to DNA, RNA and Protein Molecules in HeLa Cells and Its Lethal Effect: Comparison with cis‐ and trans‐Diammmedichloroplatinums(II)
por: Akaboshi, Mitsuhiko, et al.
Publicado: (1994)

Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy
por: Zhao, Chong, et al.
Publicado: (2016)

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
por: Uno, Kaname, et al.
Publicado: (2022)

The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric study.
por: Ormerod, M. G., et al.
Publicado: (1996)

Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin
por: C̆emaz̆ar, M, et al.
Publicado: (1999)

Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1
por: Pan, Chaoyun, et al.
Publicado: (2021)

Long-term platinum retention after treatment with cisplatin and oxaliplatin
por: Brouwers, Elke EM, et al.
Publicado: (2008)

Cisplatin-Membrane Interactions and Their Influence on Platinum Complexes Activity and Toxicity
por: Martinho, Nuno, et al.
Publicado: (2019)

Cisplatin Protein Binding Partners and Their Relevance for Platinum Drug Sensitivity
por: Möltgen, Sophie, et al.
Publicado: (2020)

Recovery of platinum(0) through the reduction of platinum ions by hydrogenase-displaying yeast
por: Ito, Rio, et al.
Publicado: (2016)

Platinum
Publicado: (1860)

Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer
por: Takekuma, Munetaka, et al.
Publicado: (2015)

A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer
por: Albany, Costantine, et al.
Publicado: (2020)

Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study
por: Sayal, Karen, et al.
Publicado: (2015)

Identification of Cisplatin-Binding Proteins Using Agarose Conjugates of Platinum Compounds
por: Karasawa, Takatoshi, et al.
Publicado: (2013)

Phenethylisothiocyanate Potentiates Platinum Therapy by Reversing Cisplatin Resistance in Cervical Cancer
por: Mahapatra, Elizabeth, et al.
Publicado: (2022)

Erratum: Thermal Expansion of Platinum and Platinum-Rhodium Alloys
por: Edsinger, RE, et al.
Publicado: (2014)

Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum‐based chemotherapy
por: Taniyama, Daiki, et al.
Publicado: (2021)

Platinum Amalgam
por: Chase,
Publicado: (1872)

About Platinum
Publicado: (1890)

The Shortage of Platinum
Publicado: (1916)

Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?
por: Alfonso-Triguero, Paula, et al.
Publicado: (2023)

Factors affecting platinum concentrations in human surgical tumour specimens after cisplatin.
por: Stewart, D. J., et al.
Publicado: (1995)

Structural damage of chicken red blood cells exposed to platinum nanoparticles and cisplatin
por: Kutwin, Marta, et al.
Publicado: (2014)

Semen and serum platinum levels in cisplatin‐treated survivors of germ cell cancer
por: Malone, Eoghan R., et al.
Publicado: (2021)

Toll‐like receptor 4 is activated by platinum and contributes to cisplatin‐induced ototoxicity
por: Babolmorad, Ghazal, et al.
Publicado: (2021)

Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer
por: Walsh, Christine S., et al.
Publicado: (2021)

Release of Cytokines from Human Umbilical Vein Endothelial Cells Treated with Platinum Compounds in vitro
por: Shi, Yucheng, et al.
Publicado: (1998)

Comparison of Intracellular Stress Response of NCI-H526 Small Cell Lung Cancer (SCLC) Cells to Platinum(II) Cisplatin and Platinum(IV) Oxoplatin
por: Hamilton, Gerhard
Publicado: (2014)

Simple Trans-Platinum Complex Bearing 3-Aminoflavone Ligand Could Be a Useful Drug: Structure-Activity Relationship of Platinum Complex in Comparison with Cisplatin
por: Fabijańska, Małgorzata, et al.
Publicado: (2020)

1,1′-Bis(diphenylphosphino)ferrocene Platinum(II) Complexes as a Route to Functionalized Multiporphyrin Systems
por: Plutino, Maria Rosaria, et al.
Publicado: (2021)

Combination chemotherapy with taxane and platinum in patients with salivary gland carcinoma: a retrospective study of docetaxel plus cisplatin and paclitaxel plus carboplatin
por: Onaga, Ryutaro, et al.
Publicado: (2023)

Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum-Sensitive, Platinum-Resistant, and Platinum-Refractory Epithelial Ovarian Cancer
por: Cantón-Romero, Juan Carlos, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_flnkuq7l4h2lm1s33oftnrn2nt